NCT06423599View on ClinicalTrials.gov

Effect of Weight Loss on Physical and Cardiac Performance in People With Obesity and Heart Failure

PHASE2/PHASE3RecruitingINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

May 17, 2024

Primary Completion Date

June 30, 2026

Study Completion Date

December 30, 2026

Conditions
Heart Failure With Reduced Ejection FractionObesityWeight LossChronic Heart Failure
Interventions
DRUG

Semaglutide Injectable Product

Weight loss using Semaglutide

DIETARY_SUPPLEMENT

Calorie-restricted diet

Weight loss by calorie-restricted diet program followed by a weight loss maintenance follow-up program

Trial Locations (1)

DK-2650

RECRUITING

Amager and Hvidovre Hospital University of Copenhagen, Copenhagen

All Listed Sponsors
lead

Jens D Hove, MD,PHD

OTHER